Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol for induction in cardiac valve replacement
ChiCTR2000040650Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Guangxi Medical University
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Cardiac valve disease (VHD) comparing Remimazolam Tosilate group with Propofol group (2 arms). Primary endpoint: MAP change value during induction of general anesthesia. Planned start Dec 2020; status: not yet recruiting.
02
Drugs
remimazolampropofol
03
Conditions
Cardiac valve disease (VHD)
Beyond the preview
Go deeper on ChiCTR2000040650.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000040650.